Skeletal muscle blood flow is not a determinant of insulin resistance in essential hypertension

Journal of Hypertension

Volumn 15, Issue 1, 1997, Pages 73-77

  Hunter, Steven J ^a   Harper, Roy ^a   Ennis, Cieran N ^a   Sheridan, Brian ^a   Atkinson, A Brew ^a   Bell, Patrick M ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Blood flow; Hypertension; Insulin resistance

Indexed keywords

INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE TRANSPORT; HEMODYNAMICS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEG BLOOD FLOW; MALE; MUSCLE BLOOD FLOW; NORMAL HUMAN; OUTPATIENT; PRIORITY JOURNAL; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0031045833     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715010-00007     Document Type: Article

References (29)

1. Ferranini E, Buzzigoli G, Bonadonna R, Giorico MA, Olegini M, Graziadei L, et al.: Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350-357.
2. Rooney D, Neely RDG, Ennis CN, Bell NP, Sheridan B, Atkinson AB, et al.: Insulin action and hepatic glucose cycling in essential hypertension. Metabolism 1992, 41:317-324.
3. Capaldo B, Lembo G, Napoli R, Rendina V, Albano G, Sacca L, et al.: Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 1991, 40:1320-1322.
4. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M: Hyperinsulinaemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985, 75:809-817.
5. Welborn TA, Breckenridge A, Rubinstein AH: Serum insulin in essential hypertension and in peripheral vascular disease. Lancet 1966, 1:1336-1337.
6. Anderson EA, Mark AL: The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension 1993, 21:136-141.
7. Laakso M, Edelman SV1 Brechtel G, Baron AD: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest 1990, 85:1844-1853.
8. Dela F, Larsen JJ, Mikines KJ, Galbo H: Normal effect of insulin to stimulate leg blood flow in NIDDM. Diabetes 1995, 44:221-226.
9. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994, 94:1172-1179.
10. Vollenweider P, Tappy L, Randin D, et al.: Differential effects of hyperinsulinaemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 1993, 92:147-154.
11. Laakso M, Edelman SV, Brechtel G, Baron AD: Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992, 41:1076-1083.
12. Pollare T, Lithell H, Selinus I, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989, 321:868-873.
13. 2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. Diabetes 1995, 44:665-671.
14. Kodama J, Katayama S, Tanaka K, Itabashi A, Kawazu S, Ishii J: Effect of captopril on glucose concentration. Possible role of augmented postprandial forearm blood flow. Diabetes Care 1990, 13:1990.
15. Pollare T, Lithell H, Morlin C, Prantare H, Hvarfner A, Ljunghall S: Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 1989, 7:551-559.
16. Randin D, Vollenweider P, Tappy L. Jequier E, Nicod P, Scherrer U: Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol 1994, 266:R809-R816.
17. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 1994, 94:2511-2515.
18. Harper R, Ennis CN, Sheridan B, Atkinson AB, Johnson GD, Bell PM: Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension. BMJ 1994, 309:226-230.
19. Tham TCK, McCaffrey PM, Whitehead EM, Silke B, Riddel JG: Reproducibility of forearm blood flow measurements in healthy volunteers using computer-assisted strain gauge venous occlusion plethysmography. J Pharm Med 1994, 4:173-178.
20. Utrianinen T, Malmstrom R, Makimattila S, Yki-Jarvinen H: Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects. Diabetologia 1995, 38:555-564.
21. Baron AD, Brechtel-Hook G, Johnson A, Hardin D: Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension 1992, 21:129-135.
22. Baron AD, Steinberg H, Brechtel G, Johnson A: Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol 1994, 266:E248-E253.
23. Julius S, Gudbrandsson T, Jamerson K, Shahab ST, Anderson O: The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991, 9:983-986.
24. Lilloja S, Young AA, Culter CL, Ivy JL, Abbot WGH, Zawadeski JK, et al.: Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987, 80:415-425.
25. Anderson EA, Hoffman RP, Balon TW, Sinket CA, Mark AL: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991, 87:2246-2252.
26. Gallen IW, MacDonald IA: Effects of blood glucose concentration on thermogenesis and glucose disposal during hyperinsulinaemia. Clin Sci 1990, 79:279-285.
27. Kelley DE, Reilly JP, Veneman T, Mandarino LJ: Effects of insulin on skeletal muscle storage, oxidation and glycolysis in humans. Am J Physiol 1990, 258:E923-E929.
28. Natali A, Bonadonna R, Santoro D, Galvan AQ, Baldi S, Frascerra S, et al.: Insulin resistance and vasodilation in essential hypertension. Studies with adenosine. J Clin Invest 1994, 94:1570-1576.
29. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL: Insulin increases sympathetic activity but not blood pressure in border-line hypertensive humans. Hypertension 1992, 19:621-627.